Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
about
Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetesEndothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress?Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinideInfluence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice.Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes.Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme.Esculin improves dyslipidemia, inflammation and renal damage in streptozotocin-induced diabetic rats.A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markersCo-Ingestion of Whey Protein with a Carbohydrate-Rich Breakfast Does Not Affect Glycemia, Insulinemia or Subjective Appetite Following a Subsequent Meal in Healthy Males.Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes.The effects of postprandial glucose and insulin levels on postprandial endothelial function in subjects with normal glucose tolerance.Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injurySafety and efficacy of linagliptin in type 2 diabetes patients with common renal and cardiovascular risk factors.The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.Intrinsic disorder in biomarkers of insulin resistance, hypoadiponectinemia, and endothelial dysfunction among the type 2 diabetic patients.Expression profile of neuro-endocrine-immune network in rats with vascular endothelial dysfunction.Potential cardiovascular effects of incretin-based therapies.Cardiovascular effects of gliptins.Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes.The cardiovascular safety of incretin-based therapies: a review of the evidence.The traditions and risks of fasting for lipid profiles in patients with diabetes.Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin.Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies.Protective role of dairy and its constituents on vascular function independent of blood pressure-lowering activities.Acute Peanut Consumption Alters Postprandial Lipids and Vascular Responses in Healthy Overweight or Obese Men.Flavanone-rich citrus beverages counteract the transient decline in postprandial endothelial function in humans: a randomised, controlled, double-masked, cross-over intervention study.Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.Comment on: van Dijk et al. Exercise therapy in type 2 diabetes: is daily exercise required to optimize glycemic control? Diabetes Care 2012;35:948-954.Association between urinary albumin excretion and low-density lipoprotein heterogeneity following treatment of type 2 diabetes patients with the dipeptidyl peptidase-4 inhibitor, vildagliptin: a pilot study.Improved insulin sensitivity and lower postprandial triglyceride concentrations after cold-pressed turnip rapeseed oil compared to cream in patients with metabolic syndrome.
P2860
Q24628948-E8AE1F9E-4044-4462-8992-9D2190097D4EQ26851362-804136F5-8E14-48BB-A582-2327F4867B78Q26865976-507352A8-D308-45BD-8849-0ED10099DC96Q33718016-BE0275FB-2D72-42D6-B9C1-6D15F836EB56Q35677365-7E4EB580-C629-41DA-B146-0D5E2EC7D9D9Q35777074-5FFA428B-C56F-4F46-A701-6311B276070BQ35836490-B96AC320-6E5D-4CA7-87AC-1C3C5F189394Q35838203-DD661EC3-5C63-4BC4-BE93-7614EAF911F8Q35939803-A02FAD7C-BB36-4D39-A812-BED3D8B9E64BQ36284121-F35982CD-8FD8-423D-A315-A9CE9E71E6B9Q36316459-011780E5-902F-4C07-AA29-9A57D5A43A33Q36402823-A3D614D4-B080-464F-ACB5-7DD20FBD6494Q36711841-2ADF1DAE-674B-4C28-AEB7-F866BE2E5247Q36883337-5713F8E8-F809-4794-85F9-80246B16AC37Q37366826-229638A2-1360-4BAA-B361-293DA6D71ECEQ37649609-8A1C898C-1874-481B-ABC0-8B4FF2FCE6BDQ37714635-D4B59BB1-9D50-4DB1-B569-B2EF96FD623DQ37990619-B2938935-E9B0-4A63-901B-4BCD6D703068Q38072259-491D40F6-EB35-4B67-8761-F24FB52A3423Q38113092-97D71376-933F-4070-B443-05A0961E4C48Q38134902-7D0EED30-0A8D-4A42-85A5-38F6B9136779Q38267139-155782AD-0F9B-41E4-98D9-312F0BF3627FQ38386992-9E466CCF-9D84-4664-8318-69B517BC54F7Q38460480-7E12A14B-91EF-41C6-A1E2-71A540A31D3BQ38507394-3E960EEE-300D-4EDF-A504-0D5B84DEDD2AQ38868355-9C3F3566-B322-4A77-AAC5-6538A8EA36B6Q39033673-4C0AC387-5B8D-4DA7-B340-AD5CD4BCA1A3Q42145401-D04FF3CE-C9CD-438D-8D5F-BE5429637B52Q43189485-C6E63C1F-C19A-4780-97E6-237BAC929761Q43475498-0F30E386-871F-4D31-8573-4DD07B8A324AQ53821936-BE330F79-18E5-48AD-B8D9-C90AF5D2748E
P2860
Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Postprandial hyperlipidemia, e ...... cular risk: focus on incretins
@ast
Postprandial hyperlipidemia, e ...... cular risk: focus on incretins
@en
type
label
Postprandial hyperlipidemia, e ...... cular risk: focus on incretins
@ast
Postprandial hyperlipidemia, e ...... cular risk: focus on incretins
@en
prefLabel
Postprandial hyperlipidemia, e ...... cular risk: focus on incretins
@ast
Postprandial hyperlipidemia, e ...... cular risk: focus on incretins
@en
P2093
P2860
P921
P356
P1476
Postprandial hyperlipidemia, e ...... cular risk: focus on incretins
@en
P2093
Juraj Koska
Peter D Reaven
Sameer Ansar
P2860
P2888
P356
10.1186/1475-2840-10-61
P407
P5008
P577
2011-07-07T00:00:00Z
P5875
P6179
1041012478